United States· US:59212-447_1e311326-d555-4a01-91a5-f53077a450c4
PARNATE
A tranylcypromine product containing tranylcypromine sulfate, registered in United States by Advanz Pharma (US) Corp.. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tranylcypromine is registered in 12 of 19 countries.
Countries holding a registration under ATC N06AF04 (tranylcypromine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Tranylcypromine · ATC N06AF04
12 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRANYLCYPROMINE SULFATE
- Manufacturer
- Advanz Pharma (US) Corp.
- Country
- United States (US)
- ATC code
- N06AF04
- ATC class
- Tranylcypromine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc115921244710100 TABLET, FILM COATED in 1 BOTTLE (59212-447-10)
- ndc1159212-447-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
197 interactions on record for tranylcypromine.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tranylcypromine · interactions on record
197 records
- 45 severe
- 134 moderate
- 11 minor
- 7 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tranylcypromine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenTranylcypromin Holsten 10 mg Filmdragerad tablettHolsten Pharma GmbH
- SwitzerlandTranylcypromine Rivopharm 10 mg, compressa rivestita con filmRivopharm SA
- NetherlandsTranylcypromine Aristo 10 mg, filmomhulde tablettenAristo Pharma GmbH
- SpainTRANILCIPROMINA ARISTO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAristo Pharma Gmbh
- United KingdomTranylcypromine 10mg tabletsTeva UK Ltd
- NorwayJatrosomAristo Pharma
- GermanyJatrosomAristo Pharma Gmbh (Art 57)
- IrelandParnate 10 mg coated tabletsAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Tranylcypromin Aristo
- Germany · Jatrosom, Tranylcypromin Aristo
- Denmark · Abbonate, Tranylcypromin Holsten
- Spain · Tranilcipromina Aristo
- Finland · Abbonate
- United Kingdom (Northern Ireland) · Parnate, Tranylcypromine
- Ireland · Parnate, Tranylcypromine Eignapharma
- Iceland · Abbonate
- Netherlands · Tracydal, Tranylcypromine Activase
- Norway · Abbonate, Tranylcypromine Afortas
- Sweden · Abbonate, Tranylcypromin Holsten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d71b0554-65ba-45cd-b33d-cce9493a96eb GET /v1/drugs/d71b0554-65ba-45cd-b33d-cce9493a96eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "TRANYLCYPROMINE SULFATE",
"productndc": "59212-447",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA012342",
"marketing_category": "NDA"
}See everything about tranylcypromine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.